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as criteria for accurate identiﬁ  cation 
of bacterial organisms at the species 
level (8). In this patient, 2 A. rimae 
isolates were recovered from 2 dif-
ferent blood-culture bottles drawn 48 
h apart, suggesting that A. rimae was 
not just a bypassing organism but in-
deed responsible for septicemia. In 
these specimens, S. gordonii was also 
isolated. Both species have been de-
scribed as belonging to the oral ﬂ  ora, 
suggesting that these ﬂ  ora  probably 
were the source for mixed septicemia 
in the patient. A. rimae was isolated as 
the patient was presenting with clini-
cal features of septic shock, suggest-
ing that A. rimae may have contrib-
uted to the shock. Antimicrobial drug 
treatment based on in vitro A. rimae 
susceptibility proﬁ   le, along with re-
animation measures, allowed for the 
patient’s recovery.
This case report illustrates the 
usefulness of 16S rDNA sequencing 
for accurate identiﬁ  cation of anaero-
bic organisms and suggests that A. 
rimae should be added to the list of 
organisms responsible for bacteremia 
in patients.
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Systemic Infection 
with Enteric 
Adenovirus in 
Immunocompetent 
Child with 
Haemophilus 
inﬂ  uenzae Disease 
To the Editor: Recent articles 
have reported enteric human adenovi-
ruses (HAdVs) types 40 and 41, pre-
viously thought to be restricted to the 
gastrointestinal tract (1), in multiple 
organ systems of a deceased immuno-
deﬁ  cient child (2) and in respiratory 
specimens of children with acute re-
spiratory illnesses (3). Here we pres-
ent a case in which enteric HAdV-40 
was found in the cerebrospinal ﬂ  uid 
(CSF) and blood of an apparently im-
munocompetent child with Haemo-
philus inﬂ  uenzae invasive disease.
The patient, a 10-month-old pre-
viously healthy Thai boy, met the cri-
teria for a clinical case of encephalitis 
(4) and, after informed consent was 
obtained, was enrolled in the study 
of causes of encephalitis in Thailand 
(collaboration between the US Cen-
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Figure. 16S rDNA maximum-likelihood phylogenetic tree showing the relationships of 
a blood isolate with Atopobium species. GenBank accession numbers are indicated in 
brackets. 16S rDNA sequence of Actinomyces bovis was used as an outgroup. Bootstrap 
values >90% as indicated at nodes. Scale bar indicates 0.02 substitutions per nucleotide 
position.
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Atopobium rimae  [X67149]
Atopobium parvulum [X67150]
Atopobium fossor [AB015945]
Atopobium minutum [X67148]
Atopobium oviles [AJ251324]
Atopobium vaginae [AJ585206]
Actinomyces bovis [X81061]
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ters for Disease Control and Preven-
tion [CDC] and the Ministry of Health 
of Thailand). Clinical and laboratory 
information was collected from the 
medical record. Biologic specimens 
were sent to CDC and to the Thailand 
National Institute of Health, Non-
thaburi, Thailand, for extensive test-
ing for a broad range of pathogens po-
tentially associated with encephalitis 
(4). Data on the clinical course of the 
patient are presented in the Table.
HAdV DNA was ﬁ  rst detected in 
the CSF specimen collected on De-
cember 12, 2003, by an in-house pan-
AdV PCR screening assay conducted 
as part of the study protocol. Amplicon 
sequences obtained closely matched 
that of HAdV-40. This unexpected 
result was conﬁ  rmed by independent 
PCR assays on separate aliquots of 
the same specimen, a broadly reactive 
real-time TaqMan PCR targeting the 
hexon gene, and a HAdV 40/41 type-
speciﬁ   c real-time Förster resonance 
energy transfer (FRET) PCR assay 
targeting the ﬁ  ber gene (5). Sequences 
of the hexon gene hypervariable re-
gions 1–6 that provide type speciﬁ  city 
(6) showed a single nonsynonymous 
base substitution (C→T; Thr→Ile) at 
nucleotide position 107 of the HAdV-
40 prototype strain Dugan (GenBank 
accession no. DQ115441).
HAdV-40 DNA with identical se-
quences was also detected in the acute-
phase serum specimen also collected 
on December 12, 2003, but not in the 
convalescent-phase specimen collec-
ted on January 7, 2004. An oropha-
ryngeal swab specimen obtained on 
December 12 was PCR-negative for 
HAdV DNA. Although no increase in 
levels of HAdV antibodies was detect-
ed by indirect enzyme immunoassay 
against pan-AdV antigen, microneu-
tralization assay demonstrated a rise 
in levels of type-speciﬁ  c neutralizing 
antibodies to HAdV-40 between the 
acute-phase (<1:10) and convalescent-
phase (1:40) serum specimens.
The results of other testing con-
ducted on the same specimens as part 
of the study protocol were the follow-
ing. CSF obtained on December 12, 
2003, was negative by broad-speciﬁ  c-
ity PCRs for bacterial 16S RNA and 
viral agents (alphaviruses, ﬂ  avivi-
ruses, bunyaviruses, human herpesvi-
ruses) as well as by PCR for entero-
viruses, herpes simplex virus, Nipah 
virus, Mycoplasma pneumoniae, and 
Neisseria meningitidis. CSF was also 
negative for Cryptococcus spp. by In-
dia ink technique. Serum was negative 
for acute infection with ﬂ  aviviruses 
(dengue and Japanese encephalitis vi-
ruses); alphaviruses (chikungunya vi-
rus); inﬂ  uenza viruses; human parain-
ﬂ  uenza viruses 1–3; measles, mumps, 
and rubella viruses; enteroviruses; 
Bartonella henselae; rickettsiae (R. 
typhi, Orientia tsutsugamushi, and R. 
conorii); and M. pneumoniae. Results 
of PCR on saliva specimens and sero-
logic testing for rabies were negative; 
an oropharyngeal swab specimen was 
negative by PCR for M. pneumoniae; 
and results of a smear for malaria par-
asites were negative. The patient was 
HIV negative.
Detection of HAdV-40 in CSF in 
this case was conﬁ  rmed by multiple 
PCRs with amplicon sequencing. De-
tection of virus in the acute-phase se-
rum specimen conﬁ  rms systemic infec-
tion and demonstrates that HAdV-40 
DNA found in CSF did not arise from 
contamination of the CSF at the time 
of collection. Laboratory contamina-
tion is also unlikely because the nucle-
otide sequence of the identiﬁ  ed strain 
(GenBank accession no. FJ228470) 
was not identical to the prototype ref-
erence strain used for positive control 
in the PCR. Seroconversion to HAdV-
40 provides further evidence that this 
child experienced an acute systemic 
infection with this virus.
The contribution of HAdV-40 to 
the clinical illness in this patient re-
mains unclear. He had a conﬁ  rmed 
H. inﬂ  uenzae invasive infection, 
which likely explains the initial un-
derlying illness. However, the detec-
tion of HAdV-40 coincided in time 
with the development of neurologic 
signs (new-onset seizures, ataxia) 
and widespread rash. By then, the 
patient had been receiving antimicro-
bial drug therapy for several days, his 
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Table. Clinical course of illness in 10-month-old boy with systemic infection with enteric 
adenovirus and Haemophilus influenzae disease, Thailand, 2003–2004* 
Date, 2003  Events
Dec 7 Patient hospitalized with 6-day history of fever >38°C and somnolence; 
blood culture positive for Hemophilus influenzae; isolate not typed 
(unavailable for further characterization) 
Dec 9  CSF results: pleocytosis (2,710 leukocytes/mm
3, 94% neutrophils); 
protein 178 mg/dL; glucose 11 mg/dL; CSF culture positive for H.
influenzae; CSF Gram stain positive for gram-negative coccobacilli; 
antimicrobial drug treatment (ceftriaxone) started 
Dec 11  New onset seizures, ataxia, and maculopapular rash on entire trunk and 
all extremities; no diarrhea or respiratory symptoms; brain ultrasound 
scan results within normal limits; anticonvulsant therapy (phenobarbital) 
started
Dec 12  CSF results: pleocytosis (100 leukocytes/mm
3, 60% neutrophils, 40% 
monocytes); protein 131.6 mg/dL; glucose 31 mg/dL; CSF bacterial 
culture, results negative; CSF Gram stain results negative; patient 
enrolled in the encephalitis study; initial specimens for the study collected
Dec 22  Brain ultrasound scan results within normal limits; antimicrobial drug 
treatment (ceftriaxone) discontinued 
Dec 23  CSF bacterial culture results negative; CSF Gram stain results negative; 
anticonvulsant therapy (phenobarbital) discontinued 
Dec 27 Patient discharged in improved condition; discharge diagnosis: H.
influenzae meningitis and septicemia 
Jan 7† Follow-up visit: full recovery without sequelae; convalescent-phase 
serum specimen obtained 
*CSF, cerebrospinal fluid. 
†2004.LETTERS
CSF was negative for 16S bacterial 
RNA by PCR and culture-negative 
for H. inﬂ  uenzae, and the CSF pleo-
cytosis had decreased substantially. 
These circumstances make it less 
likely that these signs were associat-
ed with the underlying H. inﬂ  uenzae 
disease and raise the possibility that 
superimposed HAdV-40 infection 
played a role. Because the patient had 
no diarrhea or respiratory symptoms, 
no evidence of immunodeﬁ  ciency, no 
stool specimen available for testing, 
and no evidence of HAdV in throat 
swab specimen, the pathogenesis of 
HAdV-40 infection in this case is 
unknown. The origin of the maculo-
papular rash concurrent with neuro-
logic symptoms in this patient is also 
unclear. Rash is not typical for H. 
inﬂ  uenzae infection and, although re-
ported for some HAdV infections (7), 
has not been previously described for 
HAdV-40/41.
In conclusion, this case demon-
strates the possibility of nongastro-
enteric, systemic infection involving 
CNS with enteric HAdV in immuno-
competent hosts. Broad-speciﬁ  city 
AdV PCR assay followed by ampli-
con sequencing enabled detection of 
this pathogen in an unexpected con-
text and can be useful in deﬁ  ning the 
nongastroenteric disease effects asso-
ciated with the enteric HAdVs. 
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Mesotherapy-
associated 
Outbreak Caused 
by Mycobacterium 
immunogenum
To the Editor: Mesotherapy, a 
procedure for medical and cosmetic 
treatment, involves use of microinjec-
tions of different biologically active 
substances into the dermis or subcuta-
neous adipose tissue. This controver-
sial practice is used for spot contour-
ing and anti-aging therapy. Concerns 
have been raised about mesotherapy 
complications, such as aseptic subcu-
taneous necrosis and cutaneous non-
tuberculous mycobacterial infections. 
Several rapidly growing mycobacte-
rial species, primarily Mycobacterium 
fortuitum, M. peregrinum, M. che-
lonae, M. abscessus, M. simiae, and 
the newly described M. massiliense, 
M. bolletii, and M. cosmeticum (1–5), 
have been reported to cause infections 
and outbreaks originating from use of 
contaminated injectable solutions or 
skin antiseptics during mesotherapy 
and other invasive cosmetic proce-
dures. We describe a mesotherapy-
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